These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24072178)

  • 21. Rapid carvedilol up-titration in hospitalized patients with left ventricular systolic dysfunction--data from the Carvedilol in Hospital: Up-titration Limits after Acute Patients Admission registry.
    Martínez-Sellés M; Datino T; Alhama M; Barrueco N; Castillo I; Fernández-Avilés F
    J Cardiovasc Med (Hagerstown); 2010 May; 11(5):352-8. PubMed ID: 20154635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis.
    Schleman KA; Lindenfeld JA; Lowes BD; Bristow MR; Ferguson D; Wolfel EE; Abraham WT; Zisman LS
    J Card Fail; 2001 Mar; 7(1):4-12. PubMed ID: 11264544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential long-term effects of carvedilol on proinflammatory and antiinflammatory cytokines, asymmetric dimethylarginine, and left ventricular function in patients with heart failure.
    Alfieri AB; Briceno L; Fragasso G; Spoladore R; Palloshi A; Bassanelli G; Montano C; Arioli F; Cuko A; Ruotolo G; Margonato A
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):49-54. PubMed ID: 18594474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
    Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR
    J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
    Gattis WA; O'Connor CM; Gallup DS; Hasselblad V; Gheorghiade M;
    J Am Coll Cardiol; 2004 May; 43(9):1534-41. PubMed ID: 15120808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.
    Franciosa JA; Massie BM; Lukas MA; Nelson JJ; Lottes S; Abraham WT; Fowler M; Gilbert EM; Greenberg B;
    Am Heart J; 2004 Oct; 148(4):718-26. PubMed ID: 15459606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.
    Maack C; Elter T; Nickenig G; LaRosee K; Crivaro M; Stäblein A; Wuttke H; Böhm M
    J Am Coll Cardiol; 2001 Oct; 38(4):939-46. PubMed ID: 11583862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
    Otterstad JE; Ford I
    Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
    Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
    Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers.
    Lindenfeld J; Robertson AD; Lowes BD; Bristow MR;
    J Am Coll Cardiol; 2001 Dec; 38(7):1950-6. PubMed ID: 11738299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of carvedilol on ventriculo-arterial coupling in patients with heart failure.
    Razzolini R; Tarantini G; Boffa GM; Orlando S; Iliceto S
    Ital Heart J; 2004 Jul; 5(7):517-22. PubMed ID: 15487269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
    Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure.
    Del Sindaco D; Pulignano G; Cioffi G; Tarantini L; Di Lenarda A; De Feo S; Opasich C; Minardi G; Giovannini E; Leggio F
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8(9):675-82. PubMed ID: 17700396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta blockers improve outcome in patients with heart failure and atrial fibrillation: U.S. carvedilol study.
    Ramaswamy K
    Card Electrophysiol Rev; 2003 Sep; 7(3):229-32. PubMed ID: 14739719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical status and outcome of Japanese heart failure patients with reduced or preserved ejection fraction treated with carvedilol.
    Mori Y; Nishikawa Y; Kobayashi F; Hiramatsu K
    Int Heart J; 2013; 54(1):15-22. PubMed ID: 23428919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis.
    Packer M; Antonopoulos GV; Berlin JA; Chittams J; Konstam MA; Udelson JE
    Am Heart J; 2001 Jun; 141(6):899-907. PubMed ID: 11376302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis.
    de Groote P; Delour P; Mouquet F; Lamblin N; Dagorn J; Hennebert O; Le Tourneau T; Foucher-Hossein C; Verkindère C; Bauters C
    Am Heart J; 2007 Sep; 154(3):589-95. PubMed ID: 17719311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.